Delivery Order SPE2DB24D2205-SPE2DB25FEAKZ
- Not listed
- This federal contract award, valued at $27,797.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,203,118 units of the medication Eliquis 5 mg tablets. The contract has a firm fixed price and an ultimate completion date of May 12, 2025. This award is not associated with a set-aside designation, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,474.20, is a delivery order for 4,568,120,588 units of the medication Eliquis 2.5 mg tablet 60s. The contract is a firm fixed-price, non-set-aside arrangement with a performance period extending through May 5, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract...
- This federal contract award, valued at $28,034.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,941,326 units of the medication Eliquis 5 mg tablet, with an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,675.43 firm-fixed-price delivery order is for the supply of 4,568,161,347 units of Eliquis 5 mg tablets. The contract has an ultimate completion date of May 7, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a $39,809.25 Firm Fixed Price Delivery Order, is for the supply of 4,568,058,005 units of the prescription medication Eliquis 5 mg tablets. The contract has an ultimate completion date of April 29, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,111.87, is a delivery order for the supply of Eliquis 5 mg tablets. The contract is a firm fixed-price, non-set-aside arrangement with a performance period through May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award, valued at $12,247.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order (SPE2DB25FW6J0) for 4,567,968,810 units of the medication Eliquis 5 mg tablet. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 21, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- This federal contract award, valued at $16,031.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract to supply 4,567,998,897 units of the medication Eliquis 5 mg tablets. The contract has a firm fixed price and an ultimate completion date of April 23, 2025. This award is not associated with a set-aside program and represents open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,924.59 delivery order contract is for the supply of 4,567,925,187 tablets of the medication Eliquis 5 mg. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $5,896.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,999,036 units of Eliquis 2.5 mg tablets, with a completion date of April 23, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC)...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEAKZDelivery Order
This federal contract award, valued at $45,525.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,780,779 units of the prescription medication Eliquis 5 mg tablet. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 3, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.5k | 4/2/25 |